XML 23 R8.htm IDEA: XBRL DOCUMENT v3.22.2.2
EPT - Condensed Consolidated Statements of Equity for the three and nine months ended September 30, 2022 and 2021 (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common stock
Additional paid-in capital
Distributions in excess of accumulated earnings
Accumulated other comprehensive income, net
Noncontrolling interest
Balance at period beginning (in shares) at Dec. 31, 2020   64,999        
Balance at period beginning at Dec. 31, 2020 $ 6,183,192 $ 6 $ 6,876,326 $ (861,193) $ (14,729) $ 182,782
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 371,566     351,680   19,886
Change in fair value of derivatives and amortization of swap settlements 5,607       5,417 190
Change in fair value of marketable debt securities, net 356       344 12
Issuance of common stock under:            
Stock option and restricted stock plans, net (in shares)   112        
Stock option and restricted stock plans, net 12,402 $ 1 12,401      
Sale of common stock, net (202)   (202)      
Equity based compensation costs 9,495   9,172     323
Retirement of common stock, net (in shares)   (40)        
Retirement of common stock, net (9,172)   (9,172)      
Changes in the redemption value of redeemable noncontrolling interest (4,922)   (5,499)     577
Contributions from noncontrolling interest 1,900         1,900
Distributions to noncontrolling interest (22,114)         (22,114)
Redemptions of noncontrolling interest (in shares)   10        
Redemptions of noncontrolling interest (8,407)   (7,518)     (889)
Common stock dividends (407,802)     (407,802)    
Balance at period end (in shares) at Sep. 30, 2021   65,081        
Balance at period end at Sep. 30, 2021 6,131,899 $ 7 6,875,508 (917,315) (8,968) 182,667
Balance at period beginning (in shares) at Jun. 30, 2021   65,004        
Balance at period beginning at Jun. 30, 2021 6,136,703 $ 7 6,862,879 (899,663) (9,768) 183,248
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 125,002     118,390   6,612
Change in fair value of derivatives and amortization of swap settlements 728       704 24
Change in fair value of marketable debt securities, net 99       96 3
Issuance of common stock under:            
Stock option and restricted stock plans, net (in shares)   68        
Stock option and restricted stock plans, net 15,572   15,572      
Sale of common stock, net (118)   (118)      
Equity based compensation costs 1,628   1,573     55
Changes in the redemption value of redeemable noncontrolling interest 1,673   1,253     420
Distributions to noncontrolling interest (7,257)         (7,257)
Redemptions of noncontrolling interest (in shares)   9        
Redemptions of noncontrolling interest (6,089)   (5,651)     (438)
Common stock dividends (136,042)     (136,042)    
Balance at period end (in shares) at Sep. 30, 2021   65,081        
Balance at period end at Sep. 30, 2021 6,131,899 $ 7 6,875,508 (917,315) (8,968) 182,667
Balance at period beginning (in shares) at Dec. 31, 2021   65,248        
Balance at period beginning at Dec. 31, 2021 6,176,508 $ 7 6,915,981 (916,833) (5,552) 182,905
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 238,765     223,150   15,615
Change in fair value of derivatives and amortization of swap settlements 58,084       56,124 1,960
Change in fair value of marketable debt securities, net 204       197 7
Issuance of common stock under:            
Stock option and restricted stock plans, net (in shares)   88        
Stock option and restricted stock plans, net 17,194   17,194      
Sale of common stock, net (314)   (314)      
Equity based compensation costs 7,082   6,843     239
Retirement of common stock, net (in shares)   (591)        
Retirement of common stock, net (157,951) $ (1) (157,950)      
Changes in the redemption value of redeemable noncontrolling interest 4,950   4,246     704
Contributions from noncontrolling interest 125         125
Distributions to noncontrolling interest (22,989)         (22,989)
Redemptions of noncontrolling interest (in shares)   8        
Redemptions of noncontrolling interest (10,929)   (10,128)     (801)
Common stock dividends (429,532)     (429,532)    
Balance at period end (in shares) at Sep. 30, 2022   64,753        
Balance at period end at Sep. 30, 2022 5,881,197 $ 6 6,775,872 (1,123,215) 50,769 177,765
Balance at period beginning (in shares) at Jun. 30, 2022   65,124        
Balance at period beginning at Jun. 30, 2022 6,006,585 $ 7 6,875,863 (1,073,577) 25,554 178,738
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 98,700     92,842   5,858
Change in fair value of derivatives and amortization of swap settlements 26,189       25,304 885
Change in fair value of marketable debt securities, net (92)       (89) (3)
Issuance of common stock under:            
Stock option and restricted stock plans, net (in shares)   1        
Stock option and restricted stock plans, net 155   155      
Sale of common stock, net (107)   (107)      
Equity based compensation costs 1,957   1,891     66
Retirement of common stock, net (in shares)   (372)        
Retirement of common stock, net (97,121) $ (1) (97,120)      
Changes in the redemption value of redeemable noncontrolling interest 3,727   3,195     532
Distributions to noncontrolling interest (7,748)         (7,748)
Redemptions of noncontrolling interest (8,568)   (8,005)     (563)
Common stock dividends (142,480)     (142,480)    
Balance at period end (in shares) at Sep. 30, 2022   64,753        
Balance at period end at Sep. 30, 2022 $ 5,881,197 $ 6 $ 6,775,872 $ (1,123,215) $ 50,769 $ 177,765